Reductil marketing agreement - AstraZeneca and BASF will jointly market the anti-obesity drug

被引：0
|
作者：
Fox, S
机构：
来源：
GENETIC ENGINEERING NEWS | 1999年 / 19卷 / 17期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：15 / +
页数：1
相关论文
共 50 条
  • [1] US anti-obesity drug to hit market
    不详
    CHEMICAL ENGINEER-LONDON, 1996, (623): : 6 - 6
  • [2] Anti-obesity drug development
    Bays, H
    Dujovne, C
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (09) : 1189 - 1204
  • [3] Memantine: A new anti-obesity drug
    Holt, RIG
    DIABETES OBESITY & METABOLISM, 2005, 7 (05): : 620 - 620
  • [4] Anti-obesity drug discovery: advances and challenges
    Mueller, Timo D.
    Blueher, Matthias
    Tschoep, Matthias H.
    DiMarchi, Richard D.
    NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (03) : 201 - 223
  • [5] The effects of anti-obesity drug treatment on fibromyalgia
    Tamer, N
    Katyrcy, S
    Akkus, S
    Akta, K
    Tunç, E
    Özcankaya, R
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 504 - 504
  • [6] Anti-obesity drug discovery: advances and challenges
    Timo D. Müller
    Matthias Blüher
    Matthias H. Tschöp
    Richard D. DiMarchi
    Nature Reviews Drug Discovery, 2022, 21 : 201 - 223
  • [7] Niclosamide as an anti-obesity drug: an experimental study
    Al-Gareeb, Ali I.
    Aljubory, Khalid D.
    Alkuraishy, Hayder M.
    EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY, 2017, 22 (02) : 339 - 344
  • [8] Rimonabant: more than an anti-obesity drug?
    Costa, B.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 150 (05) : 535 - 537
  • [9] An improved synthesis of Rimonabant: Anti-obesity drug
    Kotagiri, Vijay Kumar
    Suthrapu, Sashikanth
    Reddy, Jambula Mukunda
    Rao, Chitneni Prasad
    Bollugoddu, Vijaybhaskar
    Bhattacharya, Apurba
    Bandichhor, Rakeshwar
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2007, 11 (05) : 910 - 912
  • [10] The discovery and status of sibutramine as an anti-obesity drug
    Luque, CA
    Rey, JA
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 440 (2-3) : 119 - 128
12345